Literature DB >> 29332036

Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.

Juliette Heinrich1,2,3, Jean-Sébastien Vidal4,5, Axelle Simon1,2, Anne-Sophie Rigaud4,5, Olivier Hanon4,5, Jacques Epelbaum1,2,6, Cecile Viollet1,2, Emmanuelle Duron4,5.   

Abstract

BACKGROUND: Olfactory impairment is reported in mild cognitive impairment (MCI) and Alzheimer's disease (AD) and is associated with hippocampal atrophy. In elderly people, dementia with AD neuropathology and white matter lesions (WML) is common. In this context, olfactory impairment could also depend on the presence of WML.
OBJECTIVE: To assess the cross-sectional relationship between olfaction and WML in elderly subjects with MCI.
METHODS: Consecutive subjects, >65 years old, diagnosed as MCI after a comprehensive neuropsychological assessment in an expert memory center, with a brain MRI performed within a year and without major depressive state, were included. Olfaction was assessed by the Brief Smell Identification Test (BSIT). Two trained neuroradiologists, blind to cognitive and olfaction status, visually assessed hippocampal atrophy according to Scheltens' scale and WML according to Fazekas criteria.
RESULTS: Seventy-five MCI subjects (mean age (SD) = 77.1 (6.2) years, 74.7% of women) were included. After adjustment for age and sex, factors associated with low BSIT scores were older age (p = 0.007), lower BMI (p = 0.08), lower MMSE score (p = 0.05), lower FCRST (p = 0.008), hippocampal atrophy (p = 0.04), periventricular WML (p = 0.007), and deep WML burden (p = 0.005). In multivariate analysis, severe deep WML (OR (95% CI) = 6.29 (1.4-35.13), p = 0.02) remained associated with low BSIT score independently from hippocampal atrophy.
CONCLUSION: In elderly MCI subjects, low olfactory performances are associated with WML, whose progression may be slowed by vascular treatments. A longitudinal study to evaluate whether the progression of WML, hippocampal atrophy and low olfactory function, can predict accurately conversion from MCI to dementia is ongoing.

Entities:  

Keywords:  Brain white matter lesions; magnetic resonance imaging; mild cognitive impairment; olfaction

Mesh:

Year:  2018        PMID: 29332036     DOI: 10.3233/JAD-170378

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  3 in total

1.  Investigating Olfactory Gene Variation and Odour Identification in Older Adults.

Authors:  Siddharth Raj; Anbupalam Thalamuthu; Nicola J Armstrong; Margaret J Wright; John B Kwok; Julian N Trollor; David Ames; Peter R Schofield; Henry Brodaty; Perminder S Sachdev; Karen A Mather
Journal:  Genes (Basel)       Date:  2021-04-29       Impact factor: 4.096

2.  Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort.

Authors:  Sarah M Buchanan; Thomas D Parker; Christopher A Lane; Ashvini Keshavan; Sarah E Keuss; Kirsty Lu; Sarah-Naomi James; Heidi Murray-Smith; Andrew Wong; Jennifer Nicholas; David M Cash; Ian B Malone; William Coath; David L Thomas; Carole Sudre; Nick C Fox; Marcus Richards; Jonathan M Schott
Journal:  J Neurol       Date:  2020-06-24       Impact factor: 4.849

3.  Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease.

Authors:  Jeffrey N Motter; Xinhua Liu; Min Qian; Hannah R Cohen; Davangere P Devanand
Journal:  Alzheimers Dement (Amst)       Date:  2021-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.